Latest News
TA Associates, a global growth private equity firm, has promoted six investment staff members in the firm’s Boston, Menlo Park and London offices, effective 1 January 2018.
“It is an honour to recognise the well-deserved promotions of these talented and dedicated team members who have each played a vital role in generating significant value for our investors, portfolio companies and TA,” says Brian J Conway, Chairman and Managing Partner at TA Associates. “We look forward to their continued contributions as we seek growth investment opportunities and work with the management teams of our portfolio companies to reach their full potential.”
Tractel, a specialist provider of working-at-heights and safety products and solutions, is to acquire Scanclimber Oy, the Finnish-headquartered provider of mast climbing work platforms (MCWP), for an undisclosed fee.
Scanclimber supplies rack and pinion vertical access products to more than 250 clients, in Europe, North America and Asia. It has 225 employees, operates a well-invested production facility in Poland, and sells its products through a network of distributors and sales agents globally. Industry forecasts expect MCWP products to be used increasingly as an alternative to traditional scaffolding as construction methods increasingly take into account workers’ health and safety. Scanclimber is
Counter Brands, parent company of Beautycounter, a leader in safer skin care and cleaner cosmetics, has secured a strategic investment from single-family office Mousse Partners Limited.
The investment will accelerate the Company’s strategic initiatives, including the development of a more robust omni-channel business, and provide capital for investments in technology as well as digital and brand marketing. TPG Growth also participated in this round of financing, having previously invested in the Company in 2014. The terms of the transaction have not been disclosed.
Beautycounter, based in Santa Monica, CA, was launched in 2013 by Founder and CEO Gregg Renfrew. Known for
MidOcean Partners (MidOcean), a premier middle market private equity firm focused on consumer and business services, has acquired BH Cosmetics (BH), a digitally native colour cosmetics brand.
MidOcean’s investment will be used to drive BH’s continued growth and expansion.
BH’s founders will retain a significant ownership stake in the Company. Financial terms of the transaction were not disclosed.
Launched in 2009, BH is a leading, direct-to-consumer colour cosmetics brand focused on the Millennial/Generation Z consumer. BH offers a full suite of high-quality colour cosmetics including products for the face, lips, eyes, brows as well as brushes and accessories. The Company
LightBay Capital (LightBay), a Los Angeles-based private equity firm focused on middle-market opportunities, has successfully completed fundraising for its inaugural institutional fund, LightBay Investment Partners, with total committed capital of USD615 million.
The oversubscribed Fund, which LightBay officially began marketing in April 2017, exceeded its target of USD450 million with commitments from a diverse investor group, which includes leading family offices, foundations, fund of funds, insurers, pension plans, and LightBay professionals.
LightBay is led by cofounders Nav Rahemtulla and Adam Stein, who were original members of Ares Management’s private equity group (Ares) where they invested together for over 15 years.
Capidea Management has held the first closing of its third private equity fund, Capidea Kapital III K/S with commitments of DKK750 million from a group of new and existing Danish and international investors. The Fund has a target of DKK1 billion.
Capidea was established in November 2006 with the objective of making buyout investments in competitive small and medium sized companies in Denmark. Today the firm is led by four partners, Erik Balleby Jensen, Jens Thøger Hansen, Nicolai Jungersen and Martin Jørgensen.
The Fund will continue the successful strategy of the previous two funds of targeting control and highly value-accreting
Boston-based investment firm Berkshire Partners has appointed Blake Gottesman and Sam Spirn as Managing Directors effective 1 January, 2018. They join the 22 current Managing Directors of Berkshire in managing the firm and its affiliated investment funds.
The firm’s 24 Managing Directors have an average tenure of 17 years with the firm.
Gottesman originally joined Berkshire in 2007 as a Summer Associate and returned to Berkshire in 2009 after graduating from business school. Gottesman has extensive experience with Berkshire’s consumer products and retail, communications, and industrial companies. Prior to joining Berkshire, Gottesman served as Deputy Chief of Staff at the
The total value of funds business in Guernsey grew by approximately GBP20 billion over the 12 months to the end of the third quarter of this year.
Figures from the Guernsey Financial Services Commission (GFSC) show that, at the end of September 2017, the net asset value of all funds under management and administration in Guernsey stood at GBP269 billion – an 8 per cent increase on September 2016. The figures also confirm two consecutive years of growth, with the net asset value of funds growing by nearly GBP25 billion between Q3 2015 and Q3 2016.
The annual increase was
By Nick Bayley (pictured), Duff & Phelps – It’s 3 January 2018. Hallelujah! Christmas has been and gone. The festive cheer over for another year. But there’s one more gift welcoming everyone as they head back to their offices: MiFID II has officially come into effect.
What now you ask? What should you focus in on as a matter of priority, as your funds business prepares for life under this new regime?
Regulators don’t like talking about regulatory forbearance but there has already been a certain amount of this with respect to MiFID II. That said, there are certain regulatory
BioNTech AG, a biotechnology company pioneering individualised cancer immunotherapy, has completed a USD 270 million Series A round of financing. The Company previously completed a seed round fundraising in 2008.
The Series A round was led by the Redmile Group and joined by Janus Henderson Investors, Invus, Fidelity Management & Research Company and several European family offices. The Struengmann Family Office, an existing investor in BioNTech, also participated in the capital raise.
BioNTech will use the capital to further advance its clinical pipeline of individualized immunotherapies covering a number of new approaches including mRNA and CAR-T / T-Cell receptors for
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
